Basement membrane component laminin-5 is a target of the tumor suppressor Smad4

Oncogene

Volumn 26, Issue 10, 2007, Pages 1417-1427

  Zapatka, M ^a,d   Zboralski, D ^a   Radacz, Y ^a   Bockmann M ^a   Arnold, C ^b   Schoneck A ^a   Hoppe, S ^a   Tannapfel, A ^c   Schmiegel, W ^a,c   Simon Assmann, P ^b   Schwarte Waldhoff, I ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b INSERM   (France)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Basement membrane; Invasion; Laminin 5; TGF ; Tumor suppressor Smad4

Indexed keywords

KALININ; MEMBRANE PROTEIN; SMAD4 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; COLON TUMOR; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; TRANSCRIPTION REGULATION; TUMOR CELL;

ADENOCARCINOMA; ADENOMA; BASEMENT MEMBRANE; CELL ADHESION MOLECULES; CELL LINE, TUMOR; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 33847346860     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209918     Document Type: Article

References (41)

1. Aberdam D, Virolle T, Simon-Assmann P. (2000). Transcriptional regulation of laminin gene expression. Microsc Res Technol 51: 228-237.
2. Bouziges F, Simo P, Simon-Assmann P, Haffen K, Kedinger M. (1991). Altered deposition of basementmembrane molecules in co-cultures of colonic cancer cells and fibroblasts. Int J Cancer 48: 101-108.
3. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A et al. (2005). Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and betacatenin. Cells Tissues Organs 179: 56-65.
4. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B. (2001). Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 15: 2069-2082.
5. Giannelli G, Antonaci S. (2000). Biological and clinical relevanceof Laminin-5 in cancer. Clin Exp Metast 18: 439-443.
6. Givant-Horwitz V, Davidson B, Reich R. (2005). Laminin-induced signaling in tumor cells. Cancer Lett 223: 1-10.
7. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70.
8. Hlubek F, Jung A, Kotzor N, Kirchner T, Brabletz T. (2001). Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res 61: 8089-8093.
9. Imamura T, Kanai F, Kawakami T, Amarsanaa J, Ijichi H, Hoshida Y et al. (2004). Proteomic analysis of the TGF-beta signaling pathway in pancreatic carcinoma cells using stable RNA interference to silence Smad4 expression. Biochem Biophys Res Commun 318: 289-296.
10. Jazag A, Ijichi H, Kanai F, Imamura T, Guleng B, Ohta M et al. (2005). Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta. Oncogene 24: 662-671.
11. Jonson T, Heidenblad M, Hakansson P, Gorunova L, Johansson B, Fioretos T et al. (2003). Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFB1. Genes Chromosomes Cancer 36: 340-352.
12. Katayama M, Sekiguchi K. (2004). Laminin-5 in epithelial tumour invasion. J Mol Histol 35: 277-286.
13. Korang K, Christiano AM, Uitto J, Mauviel A. (1995). Differential cytokine modulation of the genes LAMA3, LAMB3, and LAMC2, encoding the constitutive polypeptides, alpha 3, beta 3, and gamma 2, of human laminin 5 in epidermal keratinocytes. FEBS Lett 368: 556-558.
14. Liotta LA, Kohn EC. (2001). The microenvironment of the tumour-host interface. Nature 411: 375-379.
15. Lohi J. (2001). Laminin-5 in theprogre ssion of carcinomas. Int J Cancer 94: 763-767.
16. Lu W, Miyazaki K, Mizushima H, Nemoto N. (2001). Immunohistochemical distribution of laminin-5 gamma2 chain and its developmental change in human embryonic and foetal tissues. Histochem J 33: 629-637.
17. Luettges J, Galehdari H, Bröcker V, Schwarte-Waldhoff I, Henne-Bruns D, Klöppel G et al. (2001). Allelic loss is often thefirst hit in thebialle lic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 158: 1677-1683.
18. Lukashev ME, Werb Z. (1998). ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8: 437-441.
19. Maitra A, Molberg K, Albores-Saavedra J, Lindberg G. (2000). Loss of dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am J Pathol 157: 1105-1111.
20. Miyaki M, Iijima T, Konishi M, Sakai K, Ishii A, Yasuno M et al. (1999). Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18: 3098-3103.
21. Mizushima H, Koshikawa N, Moriyama K, Takamura H, Nagashima Y, Hirahara F et al. (1998). Widedistribution of laminin-5 gamma 2 chain in basement membranes of various human tissues. Horm Res 50(Suppl 2): 7-14.
22. Muller N, Reinacher-Schick A, Baldus S, van Hengel J, Berx G, Baar A et al. (2002). Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells. Oncogene 21: 6049-6058.
23. Olsen J, Kirkeby LT, BrorssonMM, Dabelsteen S, Troelsen JT, Bordoy R et al. (2003). Converging signals synergistically activateth eLA MC2 promoter and lead to accumulation of thela minin gamma 2 chain in human colon carcinoma cells. Biochem J 371: 211-221.
24. Patarroyo M, Tryggvason K, Virtanen I. (2002). Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 12: 197-207.
25. Pyke C, Romer J, Kallunki P, Lund LR, Ralfkiaer E, Dano K et al. (1994). The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 145: 782-791.
26. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K. (1995). Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 55: 4132-4139.
27. Richter M, Jurek D, Wrba F, Kaserer K, Wurzer G, Karner-Hanusch J et al. (2002). Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur J Cancer 38: 1937-1945.
28. Schwarte-Waldhoff I, Klein S, Blass-Kampmann S, Hintelmann A, Eilert C, Dreschers S et al. (1999). DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression. Oncogene 18: 3152-3158.
29. Schwarte-Waldhoff I, Volpert O, Bouck N, Sipos B, Hahn S, Klein-Scory S et al. (2000). Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci USA 97: 9624-9629.
30. Simon-Assmann P, Lefebvre O, Bellissent-Waydelich A, Olsen J, Orian-Rousseau V, De Arcangelis A. (1998). The laminins: role in intestinal morphogenesis and differentiation. Ann NY Acad Sci 859: 46-64.
31. Sordat I, Bosman FT, Dorta G, Rousselle P, Aberdam D, Blum AL et al. (1998). Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol 185: 44-52.
32. Sordat I, Rousselle P, Chaubert P, Petermann O, Aberdam D, Bosman FT et al. (2000). Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment. Int J Cancer 88: 708-717.
33. Takahashi H, Oda T, Hasebe T, Aoyagi Y, Kinoshita T, Konishi M et al. (2004). Biologically different subgroups of invasiveductal carcinoma of thepancre as: Dpc4 status according to theratio of intraductal carcinoma components. Clin Cancer Res 10: 3772-3779.
34. Takahashi S, Hasebe T, Oda T, Sasaki S, Kinoshita T, Konishi M et al. (2002). Cytoplasmic expression of laminin gamma2 chain correlates with postoperative hepatic metastasis and poor prognosis in patients with pancreatic ductal adenocarcinoma. Cancer 94: 1894-1901.
35. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. (1998). Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92: 645-656.
36. Teller IC, Beaulieu JF. (2001). Interactions between laminin and epithelial cells in intestinal health and disease. Expert Rev Mol Med 2001: 1-18.
37. Thiery JP. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
38. Volmer MW, Radacz Y, Hahn SA, Klein-Scory S, Stuhler K, Zapatka M et al. (2004). Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion-promoting matricellular protein SPARC: landscaping activity of Smad4 as revealed by a 'secretome' analysis. Proteomics 4: 1324-1334.
39. Wayner EA, Gil SG, Murphy GF, Wilke MS, Carter WG. (1993). Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J Cell Biol 121: 1141-1152.
40. Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ et al. (2000). Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60: 2002-2006.
41. Yuen HW, Ziober AF, Gopal P, Nasrallah I, Falls EM, Meneguzzi G et al. (2005). Suppression of laminin-5 expression leads to increased motility, tumorigenicity, and invasion. Exp Cell Res 309: 198-210.